Intra-Arterial and Intracavitary Cancer Chemotherapy

Session I: Pharmacology and Techniques.- Pharmacokinetic Rationale for Intra-arterial Therapy.- Technical Aspects of Arterial Access and Constant Infusion.- Management, Complications, and Evaluation of Intra-arterial Infusions.- Pharmacokinetic Rationale for Intracavitary Therapy.- Surgical Principles of Intraperitoneal Access and Therapy.- Medical Principles of Intraperitoneal and Intrapleural Chemotherapy.- Session II: Clinical Trials of Intra-arterial Therapy.- Intra-arterial Therapy of Hepatic Metastases.- Intra-arterial vs Intravenous FUDR for Colorectal Cancer Metastatic to the Liver: A Northern California Oncology Group Study.- Randomized Study of Intrahepatic vs. Systemic Infusion of Fluorodeoxyuridine in Patients with Liver Metastases from Colorectal Carcinoma (Preliminary Results).- The Rationale and Methodology for Intra-arterial Chemotherapy with BCNU as Treatment for Glioblastoma.- Intra-arterial Cis-Platinum in Advanced Solid Tumors.- Hepatic Arterial Infusion of Floxuridine, Adriamycin and Mitomycin C for Primary Liver Neoplasms.- Intra-arterial Adriamycin Radiation Therapy, and Surgical Excision for Extremity, Skeletal and Soft Tissue Sarcomas.- Session III; Clinical Trials of Intracavitary Chemotherapy.- Phase I Trials and Pharmacokinetic Studies of Intraperitoneal Cisplatin, Melphalan, Methotrexate and Cytarabine.- A Phase I Trial of Intracavitary Doxorubicin (Adriamycin) Alternating with Cisplatin.- Clinical Pharmacology of Intraperitoneal (IP) Bolus Mitomycin C and Continuous IP Infusion 5-Fluorouracil.- Intraperitoneal Adriamycin and 5-Fluorouracil in Ovarian Carcinoma.- Combination Cisplatin Based Intracavitary Chemotherapy.- Intravesicle Doxorubicin for Prophylaxis in the Management of Recurrent Superficial Bladder Carcinoma — An Update.- Session IV: Current Research on Novel Approaches.- Degradable Starch Microspheres.- Magnetic Drug-Containing Microspheres.- Polymer Immobilized Doxorubicin as a Regional Therapeutic Agent.- The Use of Radiolabeled Antibody in Cancer Chemotherapy.- Intracavitary Hyperthermia and Intra-arterial Chemotherapy.- Combination Hyperthermia and Intra-arterial Chemotherapy.